REVIEW

A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening

J M Reich

Correspondence to:
Dr J M Reich, Thoracic Oncology Program, Earl A Chiles Research Institute, Portland Providence Medical Center, 7400 SW Barnes Rd, A622, Portland, OR 97225, USA; Reichje{at}dnamail.com

Background: The magnitude of overdiagnosis is a critical and unresolved issue in lung cancer (LC) screening:(1) its contribution to the increase in survival constitutes specious evidence of benefit;(2) overdiagnosed individuals who undergo resection will experience a reduction in life expectancy, partially or completely offsetting the benefit received by others in whom earlier intervention proves curative.

Method: Critical analysis of studies in opposition and support of the view that LC screening imposes a substantial burden of overdiagnosis.

Results: Approximately 25%, possibly more, of radiographically (chest x ray) diagnosed LC appears to be overdiagnosed. Based on the observed tumour volume doubling time of low dose CT identified small malignant pulmonary nodules, CT will markedly augment lead time, increasing exposure to competing lethal morbidities, thereby increasing overdiagnosis.

Conclusion: To reduce all-cause mortality, CT screening will need to reduce LC mortality by an amount that exceeds the increase in mortality attributable to surgery and loss of pulmonary reserve in persons who are overdiagnosed or pathologically understaged (ie, with occult micrometastases). Presently, there is no evidence that CT screening will achieve any reduction in LC mortality.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Overdiagnosis in lung cancer: different perspectives, definitions, implications

Peter B Bach
Thorax 2008 63: 298-300. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Reich, J. M. (2009). Lung Cancer Screening Outcomes. Radiology 253: 277-277 [Full Text]  
• Infante, M., Cavuto, S., Lutman, F. R., Brambilla, G., Chiesa, G., Ceresoli, G., Passera, E., Angeli, E., Chiarenza, M., Aranzulla, G., Cariboni, U., Errico, V., Inzirillo, F., Bottoni, E., Voulaz, E., Alloisio, M., Destro, A., Roncalli, M., Santoro, A., Ravasi, G., for the DANTE Study Group, (2009). A Randomized Study of Lung Cancer Screening with Spiral Computed Tomography: Three-year Results from the DANTE Trial. Am. J. Respir. Crit. Care Med. 180: 445-453 [Abstract] [Full Text]  
• Sozzi, G., Roz, L., Conte, D., Mariani, L., Andriani, F., Lo Vullo, S., Verri, C., Pastorino, U. (2009). Plasma DNA Quantification in Lung Cancer Computed Tomography Screening: Five-Year Results of a Prospective Study. Am. J. Respir. Crit. Care Med. 179: 69-74 [Abstract] [Full Text]  
• Bach, P. B (2008). Overdiagnosis in lung cancer: different perspectives, definitions, implications. Thorax 63: 298-300 [Full Text]